Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1801913 Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gómez-Sánchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:67–119 Rabinovitch M (2012) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 122:4306–4313 Suzuki T, Carrier EJ, Talati MH, Rathinasabapathy A, Chen X, Nishimura R, Tada Y, Tatsumi K, West JD (2018) Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 314:L118–L126 Stenmark KR, Frid M, Perros F (2016) Endothelial-to-mesenchymal transition. An evolving paradigm and a promising therapeutic target in PAH. Circulation 133:1734–1737 Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Péchoux C, Bogaard HJ, Dorfmüller P, Remy S, Lecerf F, Planté S, Chat S, Fadel E, Houssaini A, Anegon I, Adnot S, Simonneau G, Humbert M, Cohen-Kaminsky S, Perros F (2015) Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation 131:1006–1018 Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196 Sánchez-Duffhues G, García de Vinuesa A, ten Dijke P (2018) Endothelial-to-mesenchymal transition in cardiovascular diseases. Developmental signaling pathways gone awry. Dev Dyn 247:492–508 Rol N, Kurakula KB, Happé C, Bogaard HJ, Goumans M-J (2018) TGF-β and BMPR2 signaling in PAH. Two black sheep in one family. IJMS 19:2585 Ogo T, Chowdhury HM, Yang J, Long L, Li X, Torres Cleuren YN, Morrell NW, Schermuly RT, Trembath RC, Nasim MT (2013) Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 48:733–741 Morrell NW, Bloch DB, ten Dijke P, Goumans M-JTH, Hata A, Smith J, Yu PB, Bloch KD (2016) Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol 13:106–120 Spiekerkoetter E, Tian X, Cai J, Hopper RK, Sudheendra D, Li CG, El-Bizri N, Sawada H, Haghighat R, Chan R, Haghighat L, de Jesus Perez V, Wang L, Reddy S, Zhao M, Bernstein D, Solow-Cordero DE, Beachy PA, Wandless TJ, ten Dijke P, Rabinovitch M (2013) FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest 123:3600–3613 Peiffer BJ, Qi L, Ahmadi AR, Wang Y, Guo Z, Peng H, Sun Z, Liu JO (2019) Activation of BMP signaling by FKBP12 ligands synergizes with inhibition of CXCR4 to accelerate wound healing. Cell Chem Biol 26:652–661 Long L, Ormiston ML, Yang X, Southwood M, Gräf S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, Moore SD, Drake KM, Aldred MA, Yu PB, Upton PD, Morrell NW (2015) Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med 21:777–785 Urist MR (1965) Bone. Formation by autoinduction. Science 150:893–899 Goumans M-JTH, Zwijsen A, ten Dijke P, Bailly S (2018) Bone morphogenetic proteins in vascular homeostasis and disease. Cold Spring Harb Perspect Biol 10:031989 Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Löwik CWGM, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120:964–972 David L, Mallet C, Keramidas M, Lamandé N, Gasc J-M, Dupuis-Girod S, Plauchu H, Feige J-J, Bailly S (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102:914–922 Levet S, Ouarne M, Ciais D, Coutton C, Subileau M, Mallet C, Ricard N, Bidart M, Debillon T, Faravelli F, Rooryck C, Feige J-J, Tillet E, Bailly S (2015) BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus. Proc Natl Acad Sci USA 112:E3207–E3215 Brand V, Lehmann C, Umkehrer C, Bissinger S, Thier M, de Wouters M, Raemsch R, Jucknischke U, Haas A, Breuer S, Birzele F (2016) Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis. Mol Oncol 10:1603–1620 García de Vinuesa A, Abdelilah-Seyfried S, Knaus P, Zwijsen A, Bailly S (2016) BMP signaling in vascular biology and dysfunction. Cytokine Growth Factor Rev 27:65–79 Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, Huertas A, Ritvos O, Savale L, Feige J-J, Humbert M, Bailly S, Guignabert C (2019) Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension. Circ Res 124:846–855 Wang G, Fan R, Ji R, Zou W, Penny DJ, Varghese NP, Fan Y (2016) Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension. A case report. BMC Pulm Med 16:17 Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, Cavalcanti-Adam EA, Blank KG, Knaus P, Mullins MC (2019) BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics. PLoS Biol 17:e3000557 Szulcek R, Happé CM, Rol N, Fontijn RD, Dickhoff C, Hartemink KJ, Grünberg K, Tu L, Timens W, Nossent GD, Paul MA, Leyen TA, Horrevoets AJ, de Man FS, Guignabert C, Yu PB, Vonk-Noordegraaf A, van Nieuw Amerongen GP, Bogaard HJ (2016) Delayed microvascular shear adaptation in pulmonary arterial hypertension role of platelet endothelial cell adhesion molecule-1 cleavage. Am J Respir Crit Care Med 193:1410–1420 Smits J, Tasev D, Andersen S, Szulcek R, Botros L, Ringgaard S, Andersen A, Vonk-Noordegraaf A, Koolwijk P, Bogaard HJ (2018) Blood Outgrowth and proliferation of endothelial colony forming cells are related to markers of disease severity in patients with pulmonary arterial hypertension. IJMS 19:3763 Szulcek R, Bogaard HJ, van Nieuw Amerongen GP (2014) Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J Vis Exp 85:e51300 Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550 Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C (2015) STRING v10. Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43:D447–D452 Evrard SM, Lecce L, Michelis KC, Nomura-Kitabayashi A, Pandey G, Purushothaman K-R, d’Escamard V, Li JR, Hadri L, Fujitani K, Moreno PR, Benard L, Rimmele P, Cohain A, Mecham B, Randolph GJ, Nabel EG, Hajjar R, Fuster V, Boehm M, Kovacic JC (2016) Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun 7:11853 Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JSR, Howard LS, Pepke-Zaba J, Sheares KKK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ (2012) Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension. Results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186:790–796 Pickworth J, Rothman A, Iremonger J, Casbolt H, Hopkinson K, Hickey PM, Gladson S, Shay S, Morrell NW, Francis SE, West JD, Lawrie A (2017) Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling. Pulm Circ 7:768–776 Tamura Y, Phan C, Tu L, Le Hiress M, Thuillet R, Jutant E-M, Fadel E, Savale L, Huertas A, Humbert M, Guignabert C (2018) Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 128:1956–1970 Selimovic N, Bergh C-H, Andersson B, Sakiniene E, Carlsten H, Rundqvist B (2009) Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension. Eur Respir J 34:662–668 Simpson CE, Chen JY, Damico RL, Hassoun PM, Martin LJ, Yang J, Nies M, Griffiths M, Vaidya RD, Brandal S, Pauciulo MW, Lutz KA, Coleman AW, Austin ED, Ivy DD, Nichols WC, Everett AD (2020) Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension. Why novel is not always best. Eur Respir J 55:1901761 Dummer A, Rol N, Szulcek R, Kurakula K, Pan X, Visser BI, Bogaard HJ, DeRuiter MC, Goumans M-J, Hierck BP (2018) Endothelial dysfunction in pulmonary arterial hypertension. Loss of cilia length regulation upon cytokine stimulation. Pulm Circ 8:2045894018764629 Good RBB, Gilbane AJJ, Trinder SLL, Denton CPP, Coghlan G, Abraham DJJ, Holmes AMM (2015) Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol 185:1850–1858 Hopper RK, Moonen J-RAJ, Diebold I, Cao A, Rhodes CJ, Tojais NF, Hennigs JK, Gu M, Wang L, Rabinovitch M (2016) In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target slug. Circulation 133:1783–1794 Appleby SL, Mitrofan C-G, Crosby A, Hoenderdos K, Lodge K, Upton PD, Yates CM, Nash GB, Chilvers ER, Morrell NW (2016) Bone morphogenetic protein 9 enhances lipopolysaccharide-induced leukocyte recruitment to the vascular endothelium. J Immunol 197:3302–3314 Sánchez-Duffhues G, García de vinuesa A, van Pol V, Geerts ME, de Vries MR, Janson SG, van Dam H, Lindeman JH, Goumans M-JTH, ten Dijke P (2019) Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J Pathol 247:333–346 Mitrofan C-G, Appleby SL, Nash GB, Mallat Z, Chilvers ER, Upton PD, Morrell NW (2017) Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. J Biol Chem 292:13714–13726 Cooley BC, Nevado J, Mellad J, Yang D, Hilaire CS, Negro A, Fang F, Chen G, San H, Walts AD, Schwartzbeck RL, Taylor B, Lanzer JD, Wragg A, Elagha A, Beltran LE, Berry C, Feil R, Virmani R, Ladich E, Kovacic JC, Boehm M (2014) TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med 6:227–234 Chapman HA (2012) Epithelial responses to lung injury. Role of the extracellular matrix. Proc Am Thorac Soc 9:89–95 Lin F, Wang N, Zhang T-C (2012) The role of endothelial-mesenchymal transition in development and pathological process. IUBMB Life 64:717–723